PropertyValue
?:abstract
  • In December 2019, an emergence of pneumonia was detected in patients infected with a novel coronavirus (CoV) in Wuhan (Hubei, China). The International Committee on Taxonomy of Viruses named the virus severe acute respiratory syndrome­CoV­2 and the disease CoV disease­19 (COVID­19). Patients with COVID­19 present with symptoms associated with respiratory system dysfunction and hematological changes, including lymphopenia, thrombocytopenia and coagulation disorders. However, to the best of our knowledge, the pathogenesis of COVID­19 remains unclear. Therefore, understanding the mechanisms underlying the hematological changes that manifest during COVID­19 may aid in the development of treatments and may improve patient prognosis.
is ?:annotates of
?:creator
?:journal
  • Mol_Med_Rep
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Hematological changes in patients with COVID­19 (Review)
?:type
?:who_covidence_id
  • #918906
  • #979150
?:year
  • 2020

Metadata

Anon_0  
expand all